Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
Year: 2011
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
Institution: Tehran University of Medical Sciences
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2103323412
